3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Acebutolol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Acebutolol.
Acemetacin
The therapeutic efficacy of Acebutolol can be decreased when used in combination with Acemetacin.
Advertisement
Acepromazine
Acebutolol may increase the orthostatic hypotensive activities of Acepromazine.
Aceprometazine
Aceprometazine may increase the hypotensive activities of Acebutolol.
Acetohexamide
Acebutolol may increase the hypoglycemic activities of Acetohexamide.
Advertisement
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Acebutolol.
Acetylcholine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Acebutolol is combined with Acetylcholine.
Advertisement
Acetyldigitoxin
Acebutolol may increase the bradycardic activities of Acetyldigitoxin.
Adapalene
Adapalene may decrease the antihypertensive activities of Acebutolol.
Albuterol
Acebutolol may decrease the bronchodilatory activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acebutolol.
Alfentanil
Alfentanil may increase the bradycardic activities of Acebutolol.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Acebutolol.
Aliskiren
Acebutolol may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Acebutolol.
Alprenolol
Alprenolol may increase the hypotensive activities of Acebutolol.
Ambenonium
Ambenonium may increase the bradycardic activities of Acebutolol.
Ambrisentan
Acebutolol may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
Acebutolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Ambroxol-Theophylline-7-Acetate
Acebutolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Amifostine
Acebutolol may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Acebutolol may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Acebutolol.
Aminophylline
Acebutolol may decrease the bronchodilatory activities of Aminophylline.
Amiodarone
The therapeutic efficacy of Acebutolol can be increased when used in combination with Amiodarone.
Amitriptyline
Acebutolol may increase the orthostatic hypotensive activities of Amitriptyline.
Amlodipine
Amlodipine may increase the hypotensive activities of Acebutolol.
Amobarbital
The serum concentration of Acebutolol can be decreased when it is combined with Amobarbital.
Amodiaquine
The metabolism of Acebutolol can be decreased when combined with Amodiaquine.
Amoxapine
Acebutolol may increase the orthostatic hypotensive activities of Amoxapine.
Amphetamine
The risk or severity of adverse effects can be increased when Amphetamine is combined with Acebutolol.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Acebutolol.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Acebutolol.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Acebutolol is combined with Amyl Nitrite.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Acebutolol.
Apalutamide
The serum concentration of Acebutolol can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Acebutolol.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Apraclonidine
The risk or severity of adverse effects can be increased when Apraclonidine is combined with Acebutolol.
Apremilast
Apremilast may decrease the antihypertensive activities of Acebutolol.
Arbutamine
Acebutolol may decrease the bronchodilatory activities of Arbutamine.
Arformoterol
Acebutolol may decrease the bronchodilatory activities of Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Acebutolol.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Acebutolol.
Asenapine
Acebutolol may increase the orthostatic hypotensive activities of Asenapine.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Acebutolol.
Atenolol
Atenolol may increase the hypotensive activities of Acebutolol.
Atomoxetine
Atomoxetine may increase the hypertensive activities of Acebutolol.
Avanafil
Avanafil may increase the antihypertensive activities of Acebutolol.
Azelastine
Azelastine may decrease the antihypertensive activities of Acebutolol.
Azilsartan
The risk or severity of adverse effects can be increased when Acebutolol is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Acebutolol is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Acebutolol is combined with Azilsartan medoxomil.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Acebutolol.
Bambuterol
Acebutolol may decrease the bronchodilatory activities of Bambuterol.
Barbexaclone
The serum concentration of Acebutolol can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Acebutolol can be decreased when it is combined with Barbital.
Benazepril
Benazepril may increase the hypotensive activities of Acebutolol.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Acebutolol.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Acebutolol.
Bepridil
Acebutolol may increase the hypotensive activities of Bepridil.
Beractant
Acebutolol may increase the bradycardic activities of Beractant.
Betaxolol
Betaxolol may increase the hypotensive activities of Acebutolol.
Bethanechol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Acebutolol.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Acebutolol.
Bitolterol
Acebutolol may decrease the bronchodilatory activities of Bitolterol.
Bitolterol Mesylate
Acebutolol may decrease the bronchodilatory activities of Bitolterol.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Acebutolol.
Bosentan
Bosentan may increase the hypotensive activities of Acebutolol.
Bosentan Anhydrous
Bosentan may increase the hypotensive activities of Acebutolol.
Bretylium
Bretylium may increase the bradycardic activities of Acebutolol.
Brexpiprazole
Acebutolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Brimonidine
Brimonidine may increase the antihypertensive activities of Acebutolol.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Acebutolol.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Acebutolol.
Bumetanide
The risk or severity of adverse effects can be increased when Bumetanide is combined with Acebutolol.
Bunazosin
Acebutolol may increase the orthostatic hypotensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Acebutolol.
Bupranolol
Acebutolol may increase the hypotensive activities of Bupranolol.
Cabergoline
Acebutolol may increase the vasoconstricting activities of Cabergoline.
Cafedrine
Acebutolol may increase the hypotensive activities of Cafedrine.
Calfactant
Acebutolol may increase the bradycardic activities of Calfactant.
Canagliflozin
The risk or severity of adverse effects can be increased when Acebutolol is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Acebutolol is combined with Canagliflozin.
Candesartan
Acebutolol may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Acebutolol.
Captopril
Acebutolol may increase the hypotensive activities of Captopril.
Carbachol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Carbachol.
Carprofen
Carprofen may decrease the antihypertensive activities of Acebutolol.
Carteolol
Carteolol may increase the hypotensive activities of Acebutolol.
Carvedilol
Acebutolol may increase the orthostatic hypotensive activities of Carvedilol.
Celecoxib
Celecoxib may decrease the antihypertensive activities of Acebutolol.
Celiprolol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Celiprolol.
Ceritinib
Acebutolol may increase the bradycardic activities of Ceritinib.
Cevimeline
The risk or severity of adverse effects can be increased when Acebutolol is combined with Cevimeline.
Chloroquine
The metabolism of Acebutolol can be decreased when combined with Chloroquine.
Chlorothiazide
Chlorothiazide may increase the hypotensive activities of Acebutolol.
Chlorpromazine
Acebutolol may increase the orthostatic hypotensive activities of Chlorpromazine.
Chlorpropamide
Acebutolol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Acebutolol.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Acebutolol.
Cicletanine
Acebutolol may increase the hypotensive activities of Cicletanine.
Cilazapril
Acebutolol may increase the hypotensive activities of Cilazapril.
Clenbuterol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Clenbuterol.
Clevidipine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Acebutolol is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Acebutolol.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Acebutolol.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Clonixin
Clonixin may decrease the antihypertensive activities of Acebutolol.
Clozapine
Acebutolol may increase the orthostatic hypotensive activities of Clozapine.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Acebutolol.
Crizotinib
Acebutolol may increase the bradycardic activities of Crizotinib.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Acebutolol.
Curcumin
Curcumin may decrease the antihypertensive activities of Acebutolol.
Cyclopenthiazide
Acebutolol may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Acebutolol.
Dapagliflozin
The risk or severity of adverse effects can be increased when Acebutolol is combined with Dapagliflozin.
Dapiprazole
Acebutolol may increase the orthostatic hypotensive activities of Dapiprazole.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Acebutolol.
Demecarium
Demecarium may increase the bradycardic activities of Acebutolol.
Deserpidine
Acebutolol may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Acebutolol.
Deslanoside
Acebutolol may increase the bradycardic activities of Deslanoside.
Desvenlafaxine
The serum concentration of Acebutolol can be increased when it is combined with Desvenlafaxine.
Dexmedetomidine
Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Dextroamphetamine
Acebutolol may increase the orthostatic hypotensive activities of Dextroamphetamine.
Diazoxide
Diazoxide may increase the hypotensive activities of Acebutolol.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Acebutolol.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Acebutolol.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Acebutolol.
Digitoxin
Acebutolol may increase the bradycardic activities of Digitoxin.
Digoxin
Acebutolol may increase the bradycardic activities of Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Acebutolol.
Dihydroergotamine
Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Diltiazem
Diltiazem may increase the hypotensive activities of Acebutolol.
Dinutuximab
The risk or severity of adverse effects can be increased when Acebutolol is combined with Dinutuximab.
Dipivefrin
Dipivefrin may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Acebutolol.
Dipyrone
Metamizole may decrease the antihypertensive activities of Acebutolol.
Disopyramide
Disopyramide may increase the bradycardic activities of Acebutolol.
Distigmine
Distigmine may increase the bradycardic activities of Acebutolol.
Dobutamine
The risk or severity of adverse effects can be increased when Dobutamine is combined with Acebutolol.
Donepezil
Donepezil may increase the bradycardic activities of Acebutolol.
Dopamine
The risk or severity of adverse effects can be increased when Dopamine is combined with Acebutolol.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Acebutolol.
Doxazosin
Acebutolol may increase the orthostatic hypotensive activities of Doxazosin.
Doxepin
Acebutolol may increase the orthostatic hypotensive activities of Doxepin.
Dronedarone
Dronedarone may increase the bradycardic activities of Acebutolol.
Droperidol
Acebutolol may increase the orthostatic hypotensive activities of Droperidol.
Droxicam
Droxicam may decrease the antihypertensive activities of Acebutolol.
Droxidopa
Droxidopa may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Duloxetine
Acebutolol may increase the orthostatic hypotensive activities of Duloxetine.
Dyphylline
Acebutolol may decrease the bronchodilatory activities of Dyphylline.
Echothiophate
Echothiophate may increase the bradycardic activities of Acebutolol.
Edrophonium
Edrophonium may increase the bradycardic activities of Acebutolol.
Empagliflozin
The risk or severity of adverse effects can be increased when Acebutolol is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Acebutolol.
Enalaprilat
Acebutolol may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Acebutolol may increase the hypotensive activities of Enalaprilat.
Ephedrine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Ephedrine.
Epinephrine
Epinephrine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Acebutolol.
Epoprostenol
Acebutolol may increase the hypotensive activities of Epoprostenol.
Eprosartan
Eprosartan may increase the hypotensive activities of Acebutolol.
ergoloid mesylates, USP
Acebutolol may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Acebutolol may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Escitalopram
Acebutolol may increase the orthostatic hypotensive activities of Escitalopram.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Acebutolol.
Etanercept
Etanercept may decrease the antihypertensive activities of Acebutolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Acebutolol.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Acebutolol.
Etilefrine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Etilefrine.
Etodolac
Etodolac may decrease the antihypertensive activities of Acebutolol.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Acebutolol.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Acebutolol.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Acebutolol.
Felbinac
Felbinac may decrease the antihypertensive activities of Acebutolol.
Felodipine
Felodipine may increase the hypotensive activities of Acebutolol.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Acebutolol.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Acebutolol.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Acebutolol.
Fenoterol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Fenoterol.
Fentanyl
Fentanyl may increase the bradycardic activities of Acebutolol.
Ferulic Acid
Acebutolol may increase the hypotensive activities of Ferulic acid.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Acebutolol.
Fingolimod
Acebutolol may increase the bradycardic activities of Fingolimod.
Floctafenine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Floctafenine.
Fluoxetine
The serum concentration of Acebutolol can be increased when it is combined with Fluoxetine.
Flupenthixol
Acebutolol may increase the orthostatic hypotensive activities of Flupentixol.
Fluphenazine
Fluphenazine may increase the hypotensive activities of Acebutolol.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Acebutolol.
Formoterol
Acebutolol may decrease the bronchodilatory activities of Formoterol.
Fosinopril
Fosinopril may increase the hypotensive activities of Acebutolol.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Acebutolol.
Furazolidone
Furazolidone may increase the hypotensive activities of Acebutolol.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Acebutolol.
Galantamine
Galantamine may increase the bradycardic activities of Acebutolol.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Acebutolol.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Acebutolol.
Glibornuride
Acebutolol may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Acebutolol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Acebutolol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Acebutolol may increase the hypoglycemic activities of Glipizide.
Gliquidone
Acebutolol may increase the hypoglycemic activities of Gliquidone.
Glyburide
Acebutolol may increase the hypoglycemic activities of Glyburide.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Guanadrel
Guanadrel may increase the hypotensive activities of Acebutolol.
Guanethidine
Guanethidine may increase the hypotensive activities of Acebutolol.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Acebutolol.
Hexobarbital
The serum concentration of Acebutolol can be decreased when it is combined with Hexobarbital.
Hexoprenaline
Acebutolol may decrease the bronchodilatory activities of Hexoprenaline.
Hydralazine
Hydralazine may increase the hypotensive activities of Acebutolol.
Hydrochlorothiazide
Hydrochlorothiazide may increase the hypotensive activities of Acebutolol.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Acebutolol.
Hydroxychloroquine
The metabolism of Acebutolol can be decreased when combined with Hydroxychloroquine.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Acebutolol.
Icatibant
Icatibant may decrease the antihypertensive activities of Acebutolol.
Iloperidone
Acebutolol may increase the orthostatic hypotensive activities of Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Acebutolol.
Imidapril
Acebutolol may increase the hypotensive activities of Imidapril.
Imipramine
Acebutolol may increase the orthostatic hypotensive activities of Imipramine.
Indacaterol
Acebutolol may decrease the bronchodilatory activities of Indacaterol.
Indapamide
Indapamide may increase the hypotensive activities of Acebutolol.
Indobufen
Indobufen may decrease the antihypertensive activities of Acebutolol.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Acebutolol.
Indoramin
Acebutolol may increase the orthostatic hypotensive activities of Indoramin.
insulin human, rDNA origin
Acebutolol may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Acebutolol may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Acebutolol may increase the hypoglycemic activities of Insulin Pork.
Iproniazid
Iproniazid may increase the hypotensive activities of Acebutolol.
Irbesartan
Irbesartan may increase the hypotensive activities of Acebutolol.
Isavuconazole
The serum concentration of Acebutolol can be increased when it is combined with Isavuconazole.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Acebutolol.
Isoetharine
Acebutolol may decrease the bronchodilatory activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Acebutolol.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Acebutolol.
Isoproterenol
The risk or severity of adverse effects can be increased when Isoprenaline is combined with Acebutolol.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isosorbide Dinitrate is combined with Acebutolol.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Acebutolol.
Isoxsuprine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Acebutolol.
Ivabradine
Acebutolol may increase the bradycardic activities of Ivabradine.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Acebutolol.
Ketanserin
Ketanserin may increase the hypotensive activities of Acebutolol.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Acebutolol.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Acebutolol.
Labetalol
Acebutolol may increase the orthostatic hypotensive activities of Labetalol.
Lacidipine
Acebutolol may increase the hypotensive activities of Lacidipine.
Lacosamide
Acebutolol may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lanreotide
Acebutolol may increase the bradycardic activities of Lanreotide.
Latanoprost
Latanoprost may increase the hypotensive activities of Acebutolol.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Acebutolol.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Acebutolol.
Levalbuterol
Acebutolol may decrease the bronchodilatory activities of Levosalbutamol.
Levobunolol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Acebutolol.
Levodopa
Acebutolol may increase the orthostatic hypotensive activities of Levodopa.
Levomilnacipran
The serum concentration of Acebutolol can be increased when it is combined with Levomilnacipran.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Acebutolol.
Lidocaine
The serum concentration of Lidocaine can be increased when it is combined with Acebutolol.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Acebutolol.
Linezolid
Linezolid may increase the hypertensive activities of Acebutolol.
Lisdexamfetamine
Acebutolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Acebutolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisinopril
Lisinopril may increase the hypotensive activities of Acebutolol.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Acebutolol.
Lobeline
The risk or severity of adverse effects can be increased when Acebutolol is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Acebutolol.
Losartan
Losartan may increase the hypotensive activities of Acebutolol.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Acebutolol.
Lucinactant
Acebutolol may increase the bradycardic activities of Lucinactant.
Lumacaftor
The serum concentration of Acebutolol can be decreased when it is combined with Lumacaftor.
Macitentan
Acebutolol may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Acebutolol.
Malathion
Malathion may increase the bradycardic activities of Acebutolol.
Manidipine
Acebutolol may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Acebutolol.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Acebutolol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Acebutolol.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Acebutolol.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Acebutolol.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Acebutolol.
Mefloquine
Mefloquine may increase the bradycardic activities of Acebutolol.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Acebutolol.
Memantine
Memantine may increase the bradycardic activities of Acebutolol.
Mephentermine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Mephentermine.
Mephobarbital
The serum concentration of Acebutolol can be decreased when it is combined with Methylphenobarbital.
Mepirodipine
Acebutolol may increase the antihypertensive activities of Barnidipine.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Acebutolol.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Acebutolol.
Mesoridazine
Mesoridazine may increase the hypotensive activities of Acebutolol.
Metaproterenol
The risk or severity of adverse effects can be increased when Orciprenaline is combined with Acebutolol.
Metaraminol
The risk or severity of adverse effects can be increased when Metaraminol is combined with Acebutolol.
Methacholine
Acebutolol may increase the bronchoconstrictory activities of Methacholine.
Methamphetamine
Methamphetamine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Acebutolol.
Methohexital
The serum concentration of Acebutolol can be decreased when it is combined with Methohexital.
Methotrimeprazine
Acebutolol may increase the orthostatic hypotensive activities of Methotrimeprazine.
Methoxamine
The risk or severity of adverse effects can be increased when Methoxamine is combined with Acebutolol.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Acebutolol.
Methyldopa
Methyldopa may increase the atrioventricular blocking (AV block) activities of Acebutolol.
METHYLDOPA ANHYDROUS
Methyldopa may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Methylene blue
Methylene blue may increase the hypotensive activities of Acebutolol.
METHYLEPHEDRINE, DL-
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Methylergonovine
Acebutolol may increase the vasoconstricting activities of Methylergometrine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Acebutolol.
Metipranolol
Acebutolol may increase the hypotensive activities of Metipranolol.
Metoclopramide
Metoclopramide may increase the bradycardic activities of Acebutolol.
Metolazone
Metolazone may increase the hypotensive activities of Acebutolol.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Acebutolol.
Metyrosine
Acebutolol may increase the hypotensive activities of Metyrosine.
Mibefradil
Acebutolol may increase the hypotensive activities of Mibefradil.
Midodrine
Acebutolol may increase the bradycardic activities of Midodrine.
Milnacipran
The serum concentration of Acebutolol can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Acebutolol.
Minoxidil
Minoxidil may increase the hypotensive activities of Acebutolol.
Moclobemide
Moclobemide may increase the hypotensive activities of Acebutolol.
Moexipril
Moexipril may increase the hypotensive activities of Acebutolol.
Molsidomine
Molsidomine may increase the hypotensive activities of Acebutolol.
Moricizine
Moricizine may increase the hypotensive activities of Acebutolol.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Acebutolol.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Acebutolol.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Acebutolol.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Acebutolol.
N-methylephedrine
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Acebutolol.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Acebutolol.
Nadolol
Acebutolol may increase the hypotensive activities of Nadolol.
Naftifine
Naftifine may decrease the antihypertensive activities of Acebutolol.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Naproxen
Naproxen may decrease the antihypertensive activities of Acebutolol.
Nebivolol
Acebutolol may increase the hypotensive activities of Nebivolol.
Nefazodone
Acebutolol may increase the orthostatic hypotensive activities of Nefazodone.
Neostigmine
Neostigmine may increase the bradycardic activities of Acebutolol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Acebutolol.
Nesiritide
The risk or severity of adverse effects can be increased when Acebutolol is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Acebutolol.
Nicardipine
Acebutolol may increase the orthostatic hypotensive activities of Nicardipine.
Nicergoline
Acebutolol may increase the orthostatic hypotensive activities of Nicergoline.
Nicorandil
Nicorandil may increase the hypotensive activities of Acebutolol.
Nicotine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Acebutolol is combined with Nicotine.
Nifedipine
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Acebutolol.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Acebutolol.
Nilvadipine
Acebutolol may increase the hypotensive activities of Nilvadipine.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Acebutolol.
Nimodipine
Nimodipine may increase the hypotensive activities of Acebutolol.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Acebutolol.
Nitrendipine
Nitrendipine may increase the hypotensive activities of Acebutolol.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Acebutolol.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Acebutolol.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Acebutolol.
Norepinephrine
Norepinephrine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Nortriptyline
Acebutolol may increase the orthostatic hypotensive activities of Nortriptyline.
Nylidrin
The risk or severity of adverse effects can be increased when Acebutolol is combined with Nylidrin.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Acebutolol.
Obinutuzumab
Acebutolol may increase the hypotensive activities of Obinutuzumab.
Octreotide
Octreotide may increase the bradycardic activities of Acebutolol.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Acebutolol.
Olanzapine
Acebutolol may increase the orthostatic hypotensive activities of Olanzapine.
Olmesartan
Olmesartan may increase the hypotensive activities of Acebutolol.
Olodaterol
Acebutolol may decrease the bronchodilatory activities of Olodaterol.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Acebutolol.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Acebutolol.
Ouabain
Acebutolol may increase the bradycardic activities of Ouabain.
Ovine Digoxin Immune Fab
Acebutolol may increase the bradycardic activities of Digoxin Immune Fab (Ovine).
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Acebutolol.
Oxprenolol
Acebutolol may increase the hypotensive activities of Oxprenolol.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Acebutolol.
p-Hydroxyamphetamine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Hydroxyamphetamine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Acebutolol.
Paliperidone
Paliperidone may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Palmidrol
Palmidrol may decrease the antihypertensive activities of Acebutolol.
Papaverine
The risk or severity of adverse effects can be increased when Papaverine is combined with Acebutolol.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Acebutolol.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Acebutolol.
Pargyline
Pargyline may increase the hypotensive activities of Acebutolol.
Paroxetine
The serum concentration of Acebutolol can be increased when it is combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Acebutolol.
Pasireotide
Acebutolol may increase the bradycardic activities of Pasireotide.
Penbutolol
Acebutolol may increase the hypotensive activities of Penbutolol.
Pentobarbital
The serum concentration of Acebutolol can be decreased when it is combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Acebutolol.
Perazine
Perazine may increase the hypotensive activities of Acebutolol.
Pergolide
Pergolide may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Periciazine
Acebutolol may increase the orthostatic hypotensive activities of Propericiazine.
Perindopril
Perindopril may increase the hypotensive activities of Acebutolol.
Perphenazine
Perphenazine may increase the hypotensive activities of Acebutolol.
Phenelzine
Phenelzine may increase the hypotensive activities of Acebutolol.
Phenmetrazine
The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Acebutolol.
Phenobarbital
The serum concentration of Acebutolol can be decreased when it is combined with Phenobarbital.
Phenoxybenzamine
Acebutolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Phentermine
The risk or severity of adverse effects can be increased when Phentermine is combined with Acebutolol.
PHENTERMINE RESIN
The risk or severity of adverse effects can be increased when Phentermine is combined with Acebutolol.
Phentolamine
Acebutolol may increase the orthostatic hypotensive activities of Phentolamine.
Phentolamine Mesylate
Acebutolol may increase the orthostatic hypotensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Acebutolol.
Phenylephrine
The risk or severity of adverse effects can be increased when Phenylephrine is combined with Acebutolol.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Acebutolol.
Physostigmine
Physostigmine may increase the bradycardic activities of Acebutolol.
Pilocarpine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Acebutolol.
Pinacidil
Pinacidil may increase the hypotensive activities of Acebutolol.
Pindolol
Pindolol may increase the hypotensive activities of Acebutolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Acebutolol.
Pirbuterol
Acebutolol may decrease the bronchodilatory activities of Pirbuterol.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Acebutolol.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Acebutolol.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Acebutolol.
Pizotyline
Acebutolol may increase the orthostatic hypotensive activities of Pizotifen.
Polythiazide
Acebutolol may increase the hypotensive activities of Polythiazide.
Poractant alfa
Acebutolol may increase the bradycardic activities of Poractant alfa.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Acebutolol.
Prazosin
Acebutolol may increase the orthostatic hypotensive activities of Prazosin.
Primaquine
The metabolism of Acebutolol can be decreased when combined with Primaquine.
Primidone
The serum concentration of Acebutolol can be decreased when it is combined with Primidone.
Procaine
Procaine may increase the hypotensive activities of Acebutolol.
Procarbazine
Procarbazine may increase the hypotensive activities of Acebutolol.
Procaterol
The risk or severity of adverse effects can be increased when Acebutolol is combined with Procaterol.
Prochlorperazine
Prochlorperazine may increase the hypotensive activities of Acebutolol.
Promazine
Acebutolol may increase the orthostatic hypotensive activities of Promazine.
Promethazine
Promethazine may increase the hypotensive activities of Acebutolol.
Propafenone
The serum concentration of Acebutolol can be increased when it is combined with Propafenone.
Propiomazine
Acebutolol may increase the orthostatic hypotensive activities of Propiomazine.
Propiverine
Acebutolol may increase the orthostatic hypotensive activities of Propiverine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Acebutolol.
Propranolol
Propranolol may increase the hypotensive activities of Acebutolol.
Proscillaridin
Acebutolol may increase the bradycardic activities of Proscillaridin.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Acebutolol.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Acebutolol.
Quetiapine
Acebutolol may increase the orthostatic hypotensive activities of Quetiapine.
Quetiapine fumarate
Acebutolol may increase the orthostatic hypotensive activities of Quetiapine.
Quinapril
Quinapril may increase the hypotensive activities of Acebutolol.
Quinidine
Acebutolol may increase the orthostatic hypotensive activities of Quinidine.
Quinine
Quinine may increase the hypotensive activities of Acebutolol.
Racepinephrine
Racepinephrine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Ramipril
Ramipril may increase the hypotensive activities of Acebutolol.
Ranolazine
The serum concentration of Acebutolol can be increased when it is combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive activities of Acebutolol.
Regorafenib
Regorafenib may increase the bradycardic activities of Acebutolol.
Regular Insulin, Human
Acebutolol may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Acebutolol.
Rescinnamine
Acebutolol may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Acebutolol.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Acebutolol.
Rifampin
The serum concentration of Acebutolol can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Acebutolol can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Acebutolol can be decreased when it is combined with Rifaximin.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Acebutolol.
Riociguat
Acebutolol may increase the hypotensive activities of Riociguat.
Risperidone
Acebutolol may increase the hypotensive activities of Risperidone.
Ritodrine
The risk or severity of adverse effects can be increased when Ritodrine is combined with Acebutolol.
Rituximab
Acebutolol may increase the hypotensive activities of Rituximab.
Rivastigmine
Acebutolol may increase the bradycardic activities of Rivastigmine.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Acebutolol.
Ropinirole
Ropinirole may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Acebutolol.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Acebutolol.
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Acebutolol.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Acebutolol.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Acebutolol.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Acebutolol.
Salmeterol
Acebutolol may decrease the bronchodilatory activities of Salmeterol.
Salsalate
Salsalate may decrease the antihypertensive activities of Acebutolol.
Secobarbital
The serum concentration of Acebutolol can be decreased when it is combined with Secobarbital.
Selegiline
Selegiline may increase the hypotensive activities of Acebutolol.
Selexipag
Acebutolol may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Acebutolol.
Sertraline
The serum concentration of Acebutolol can be increased when it is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Acebutolol.
Sildenafil
Sildenafil may increase the antihypertensive activities of Acebutolol.
Silodosin
Acebutolol may increase the orthostatic hypotensive activities of Silodosin.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Acebutolol.
Spirapril
Acebutolol may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Acebutolol.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Acebutolol.
Sufentanil
Sufentanil may increase the bradycardic activities of Acebutolol.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Acebutolol.
Sulindac
Sulindac may decrease the antihypertensive activities of Acebutolol.
Suprofen
Suprofen may decrease the antihypertensive activities of Acebutolol.
Synephrine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Synephrine.
Tacrine
Tacrine may increase the bradycardic activities of Acebutolol.
Tadalafil
Tadalafil may increase the antihypertensive activities of Acebutolol.
Talinolol
Acebutolol may increase the hypotensive activities of Talinolol.
Tamsulosin
Acebutolol may increase the orthostatic hypotensive activities of Tamsulosin.
Tedizolid
Tedizolid Phosphate may increase the hypertensive activities of Acebutolol.
Tedizolid Phosphate
Tedizolid Phosphate may increase the hypertensive activities of Acebutolol.
Telmisartan
Telmisartan may increase the hypotensive activities of Acebutolol.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Acebutolol.
Terazosin
Acebutolol may increase the orthostatic hypotensive activities of Terazosin.
Terbutaline
The risk or severity of adverse effects can be increased when Terbutaline is combined with Acebutolol.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Terbutaline is combined with Acebutolol.
Teriflunomide
Teriflunomide may decrease the antihypertensive activities of Acebutolol.
Terlipressin
Acebutolol may increase the hypotensive activities of Terlipressin.
Tetrahydrocannabinol
Dronabinol may increase the tachycardic activities of Acebutolol.
Tetrahydrozoline
The risk or severity of adverse effects can be increased when Acebutolol is combined with Tetryzoline.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Acebutolol.
Theodrenaline
Acebutolol may increase the hypotensive activities of Theodrenaline.
Theophylline
Acebutolol may decrease the bronchodilatory activities of Theophylline.
Theophylline anhydrous
Acebutolol may decrease the bronchodilatory activities of Theophylline.
Thiamylal
The serum concentration of Acebutolol can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Acebutolol.
Thiopental
The serum concentration of Acebutolol can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Acebutolol can be decreased when it is combined with Thiopental.
Thioproperazine
Acebutolol may increase the orthostatic hypotensive activities of Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Acebutolol.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Acebutolol.
Tibolone
Acebutolol may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the hypotensive activities of Acebutolol.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Acebutolol.
Tizanidine
Tizanidine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Tofacitinib
Tofacitinib may increase the bradycardic activities of Acebutolol.
Tolazamide
Acebutolol may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Acebutolol may increase the orthostatic hypotensive activities of Tolazoline.
Tolbutamide
Acebutolol may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Acebutolol.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Acebutolol.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Acebutolol.
Toloxatone
Toloxatone may increase the hypotensive activities of Acebutolol.
Torsemide
Torasemide may increase the hypotensive activities of Acebutolol.
Tramazoline
The risk or severity of adverse effects can be increased when Acebutolol is combined with Tramazoline.
Trandolapril
Trandolapril may increase the hypotensive activities of Acebutolol.
Tranilast
Tranilast may decrease the antihypertensive activities of Acebutolol.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Acebutolol.
Travoprost
Travoprost may increase the hypotensive activities of Acebutolol.
Trazodone
Acebutolol may increase the orthostatic hypotensive activities of Trazodone.
Treprostinil
Treprostinil may increase the hypotensive activities of Acebutolol.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Acebutolol.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Acebutolol.
Tribenoside
Tribenoside may decrease the antihypertensive activities of Acebutolol.
Trichlormethiazide
Trichlormethiazide may increase the hypotensive activities of Acebutolol.
Trifluoperazine
Acebutolol may increase the orthostatic hypotensive activities of Trifluoperazine.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Acebutolol.
Trimeprazine
Alimemazine may increase the hypotensive activities of Acebutolol.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Acebutolol.
Trimipramine
Acebutolol may increase the orthostatic hypotensive activities of Trimipramine.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Acebutolol.
Tyramine
The risk or severity of adverse effects can be increased when Acebutolol is combined with Tyramine.
Tyrothricin
Tyrothricin may increase the bradycardic activities of Acebutolol.
UNOPROSTONE
Acebutolol may increase the hypotensive activities of Unoprostone.
Urapidil
Acebutolol may increase the orthostatic hypotensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Acebutolol.
Valsartan
Valsartan may increase the hypotensive activities of Acebutolol.
Vardenafil
Vardenafil may increase the antihypertensive activities of Acebutolol.
Varenicline
The risk or severity of adverse effects can be increased when Acebutolol is combined with Varenicline.
Vemurafenib
The serum concentration of Acebutolol can be increased when it is combined with Vemurafenib.
Venlafaxine
The serum concentration of Acebutolol can be increased when it is combined with Venlafaxine.
Verapamil
Acebutolol may increase the orthostatic hypotensive activities of Verapamil.
Vilanterol
Acebutolol may decrease the bronchodilatory activities of Vilanterol.
Vincamine
Acebutolol may increase the hypotensive activities of Vincamine.
Vinpocetine
Acebutolol may increase the hypotensive activities of Vinpocetine.
Xylazine
Xylazine may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Acebutolol.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Acebutolol.
Zileuton
Zileuton may decrease the antihypertensive activities of Acebutolol.
Ziprasidone
Acebutolol may increase the orthostatic hypotensive activities of Ziprasidone.
Zofenopril
Acebutolol may increase the hypotensive activities of Zofenopril.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Acebutolol.
Zuclopenthixol
Acebutolol may increase the orthostatic hypotensive activities of Zuclopenthixol.
